Sherie Masse

478 citations

16 papers · 355 indexed · h-index 12

Hepatology top 5%
- Hepatitis C virus research 10
Virology top 10%
- HIV Research and Treatment 4
Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 14
- HIV/AIDS Research and Interventions 1
Organic Chemistry
- Quinazolinone synthesis and applications 4
Epidemiology
- Hepatitis B Virus Studies 2
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 2
Molecular Biology
- DNA Repair Mechanisms 1

Co-authors: Akhteruzzaman Molla Dale J. Kempf Clarence J. Maring Hongmei Mo Gennadiy Koev Kent D. Stewart Tatyana Dekhtyar Liangjun Lu
Cited by: Hepatology Virology Infectious Diseases
Journals: Genetics (1 paper)Journal of Medicinal Chemistry (1 paper)Antimicrobial Agents and Chemotherapy (3 papers)
Partner nations: United States United Kingdom France

In The Last Decade

Sherie Masse

16 papers receiving 332 citations

Peers

Countries citing papers authored by Sherie Masse

Since Specialization

Citations

This map shows the geographic impact of Sherie Masse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherie Masse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherie Masse more than expected).

Fields of papers citing papers by Sherie Masse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherie Masse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherie Masse. The network helps show where Sherie Masse may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sherie Masse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sherie Masse Line = papers co-authored together Sherie Masse links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Hepatitis C NS5B polymerase inhibitors: Functional equivalents for the benzothiadiazine moiety Bioorganic & Medicinal Chemistry Letters ·Douglas K. Hutchinson,Charles A. Flentge,Pamela L. Donner,Rolf Wagner,Clarence J. Maring,Warren M. Kati,Yaya Liu,Sherie Masse,Tim Middleton,Hongmei Mo,Debra Montgomery,Wen Jiang,Gennadiy Koev,David W. A. Beno,Kent D. Stewart,Vincent S. Stoll,Akhteruzzaman Molla,Dale J. Kempf	2011	7
2	Synthesis and Biological Characterization of B-Ring Amino Analogues of Potent Benzothiadiazine Hepatitis C Virus Polymerase Inhibitors Journal of Medicinal Chemistry ·John T. Randolph,Charles A. Flentge,Peggy Huang,Douglas K. Hutchinson,Larry L. Klein,Hock Ben Lim,Rubina Mondal,Thomas Reisch,Debra Montgomery,Wen Jiang,Sherie Masse,Lisa E. Hernandez,Rodger F. Henry,Yaya Liu,Gennadiy Koev,Warren M. Kati,Kent D. Stewart,David W. A. Beno,Akhteruzzaman Molla,Dale J. Kempf	2009	34
3	953 CHARACTERIZATION OF RESISTANCE MUTATIONS SELECTED IN VITRO BY THE NON-NUCLEOSIDE HCV POLYMERASE INHIBITORS ABT-333 AND ABT-072 Journal of Hepatology ·G. V. Koev,Rubina Mondal,Jill Beyer,Thomas Reisch,Sherie Masse,Warren M. Kati,David Hutchinson,Charles A. Flentge,John T. Randolph,Pamela Donner,A. Krueger,Renaud Wagner,Pengke Yan,Tsung‐I Lin,Clarence J. Maring,Akhteruzzaman Molla	2009	8
4	Des-A-ring benzothiadiazines: Inhibitors of HCV genotype 1 NS5B RNA-dependent RNA polymerase Bioorganic & Medicinal Chemistry Letters ·Pamela L. Donner,Qinghua Xie,John K. Pratt,Clarence J. Maring,Warren M. Kati,Wen Jiang,Yaya Liu,Gennadiy Koev,Sherie Masse,Debra Montgomery,Akhter Molla,Dale J. Kempf	2008	16
5	Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives Bioorganic & Medicinal Chemistry Letters ·Douglas K. Hutchinson,Teresa A. Rosenberg,Larry L. Klein,Todd D. Bosse,Daniel P. Larson,Wenping He,Wen Jiang,Warren M. Kati,William E. Kohlbrenner,Yaya Liu,Sherie Masse,Tim Middleton,Akhteruzzaman Molla,Debra Montgomery,David W. A. Beno,Kent D. Stewart,Vincent S. Stoll,Dale J. Kempf	2008	13
6	Characterization of a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor, A-790742 Antimicrobial Agents and Chemotherapy ·Tatyana Dekhtyar,Teresa I. Ng,Liangjun Lu,Sherie Masse,David A. DeGoey,William J. Flosi,David J. Grampovnik,Larry L. Klein,Dale J. Kempf,Akhteruzzaman Molla	2008	5
7	Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitors Bioorganic & Medicinal Chemistry Letters ·Todd D. Bosse,Daniel P. Larson,Rolf Wagner,Doug K. Hutchinson,Todd W. Rockway,Warren M. Kati,Yaya Liu,Sherie Masse,Tim Middleton,Hongmei Mo,Debra Montgomery,Wen Jiang,Gennadiy Koev,Dale J. Kempf,Akhter Molla	2007	16
8	Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro Antiviral Research ·Liangjun Lu,Tanya Dekhtyar,Sherie Masse,Ron Pithawalla,P. Santhana Gopala Krishnan,Wei He,Teresa I. Ng,G. V. Koev,Kent D. Stewart,Daniel P. Larson	2007	29
9	Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of unsymmetrical 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthalene benzothiadiazine derivatives Bioorganic & Medicinal Chemistry Letters ·A. Chris Krueger,Darold L. Madigan,Brian E. Green,Douglas K. Hutchinson,Wen Jiang,Warren M. Kati,Yaya Liu,Clarence J. Maring,Sherie Masse,Keith F. McDaniel,Tim Middleton,Hongmei Mo,Akhteruzzaman Molla,Debra Montgomery,Teresa I. Ng,Dale J. Kempf	2007	17
10	In Vitro Selection and Characterization of Human Immunodeficiency Virus Type 2 with Decreased Susceptibility to Lopinavir Antimicrobial Agents and Chemotherapy ·Sherie Masse,Xiaozhi Lu,Tatyana Dekhtyar,Liangjun Lu,Gennadiy Koev,Feng Gao,Hongmei Mo,Dale J. Kempf,Barry Bernstein,George J. Hanna,Akhteruzzaman Molla	2007	25
11	[620] CHARACTERIZATION OF PHARMACOKINETIC/PHARMACODYNAMIC PARAMETERS FOR THE NOVEL HCV POLYMERASE INHIBITOR A-848837 Journal of Hepatology ·A. Molla,Renaud Wagner,Leyao Lu,Dian He,C.-M. Chen,G. V. Koev,Sherie Masse,Yongming Cai,Catherine Klein,David W. A. Beno,Lisa E. Hernandez,Preethi Krishnan,Ron Pithawalla,(unknown),Timothy Middleton,Robert E. Lanford,Warren M. Kati,Dale J. Kempf	2007	3
12	Discovery of imidazolidine-2,4-dione-linked HIV protease inhibitors with activity against lopinavir-resistant mutant HIV Bioorganic & Medicinal Chemistry ·William J. Flosi,David A. DeGoey,David J. Grampovnik,Hui-Ju Chen,Larry L. Klein,Tatyana Dekhtyar,Sherie Masse,Kennan C. Marsh,Hong Mei Mo,Dale J. Kempf	2006	24
13	Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring Bioorganic & Medicinal Chemistry Letters ·Todd W. Rockway,Rong Zhang,Dachun Liu,David A. Betebenner,Keith F. McDaniel,John K. Pratt,David W. A. Beno,Debra Montgomery,Wen Jiang,Sherie Masse,Warren M. Kati,Tim Middleton,Akhteruzzaman Molla,Clarence J. Maring,Dale J. Kempf	2006	22
14	Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamides Bioorganic & Medicinal Chemistry Letters ·A. Chris Krueger,Darold L. Madigan,Wen Jiang,Warren M. Kati,Dachun Liu,Yaya Liu,Clarence J. Maring,Sherie Masse,Keith F. McDaniel,Tim Middleton,Hongmei Mo,Akhteruzzaman Molla,Debra Montgomery,John K. Pratt,Todd W. Rockway,Rong Zhang,Dale J. Kempf	2006	24
15	Mutations Conferring Resistance to a Hepatitis C Virus (HCV) RNA-Dependent RNA Polymerase Inhibitor Alone or in Combination with an HCV Serine Protease Inhibitor In Vitro Antimicrobial Agents and Chemotherapy ·Hongmei Mo,Liangjun Lu,Edward Tam,Ron Pithawalla,Rubina Mondal,Sherie Masse,Tatyana Dekhtyar,Teresa I. Ng,Gennadiy Koev,Vincent S. Stoll,Kent D. Stewart,John K. Pratt,Pam Donner,Todd W. Rockway,Clarence J. Maring,Akhteruzzaman Molla	2005	87
16	Yeast Meiotic Mutants Proficient for the Induction of Ectopic Recombination Genetics ·JoAnne Engebrecht,Sherie Masse,Luther Davis,Kristine Rose,Therese Kessel	1998	25

About Sherie Masse

Sherie Masse is a scholar working on Hepatology, Virology and Infectious Diseases, having authored 16 papers that have together received 355 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (14 papers), Hepatitis C virus research (10 papers), HIV Research and Treatment (4 papers), Quinazolinone synthesis and applications (4 papers), Hepatitis B Virus Studies (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), HIV/AIDS Research and Interventions (1 paper) and DNA Repair Mechanisms (1 paper). The work is most often cited by research in Hepatology (201 citations), Virology (47 citations) and Infectious Diseases (170 citations). Sherie Masse has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Akhteruzzaman Molla, Dale J. Kempf, Clarence J. Maring, Hongmei Mo, Gennadiy Koev, Kent D. Stewart, Tatyana Dekhtyar, Liangjun Lu, Teresa I. Ng and Warren M. Kati. Their work appears in journals such as Genetics, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact